Privia Health
PRVA
203 hedge funds and large institutions have $2.62B invested in Privia Health in 2022 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 56 increasing their positions, 55 reducing their positions, and 18 closing their positions.
314% more call options, than puts
Call options by funds: $21.9M | Put options by funds: $5.28M
294% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 18
34% more funds holding
Funds holding: 151 → 203 (+52)
29% more capital invested
Capital invested by funds: $2.03B → $2.62B (+$589M)
6.6% more ownership
Funds ownership: 64.25% → 70.86% (+6.6%)
2% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$33.3M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$25.5M |
| 3 |
Morgan Stanley
New York
|
+$22.6M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$21.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$18.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$100M |
| 2 |
SIG
Senator Investment Group
New York
|
-$33.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19.2M |
| 4 |
Bank of New York Mellon
New York
|
-$13.4M |
| 5 |
SAM
Silvercrest Asset Management
New York
|
-$10.6M |
PRVA Hedge Fund Activity: Q3 2022 in Review
203 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q3 2022, worth a combined $2.62B — up 29% from $2.03B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new PRVA positions and 18 closed out — a net gain of 53 holders — while 56 added to existing stakes and 55 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $33.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $100M.
- 203 institutional investors held Privia Health (PRVA) as of Q3 2022, up from 151 in Q2 2022.
- Funds reported $2.62B of Privia Health stock for Q3 2022, up 29% quarter-over-quarter.
- 71 funds opened new Privia Health positions in Q3 2022 and 18 closed out, a net change of +53 holders.
- The largest Privia Health buyer in Q3 2022 was Citadel Advisors, an estimated $33.3M added.
- The largest Privia Health seller in Q3 2022 was T. Rowe Price Associates, an estimated $100M sold.
Based on aggregated 13F filings for Q3 2022.